Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral, Small-Molecule Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitor AZD6244 (ARRY-142886) in Patients With Advanced CancersADJEI, Alex A; COHEN, Roger B; MALONEY, Lara et al.Journal of clinical oncology. 2008, Vol 26, Num 13, pp 2139-2146, issn 0732-183X, 8 p.Article

A Phase 1 Dose-Escalation Study of ARRY-520, a Kinesin Spindle Protein Inhibitor, in Patients With Advanced Myeloid LeukemiasJEAN KHOURY, Hanna; GARCIA-MANERO, Guillermo; KARAN, Sharon et al.Cancer. 2012, Vol 118, Num 14, pp 3556-3564, issn 0008-543X, 9 p.Article

Isolation of anti-MISIIR scFv molecules from a phage display library by cell sorter biopanningYUAN, Qing-An; ROBINSON, Matthew K; SIMMONS, Heidi H et al.Cancer immunology and immunotherapy. 2008, Vol 57, Num 3, pp 367-378, issn 0340-7004, 12 p.Article